Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma

por Angeles, Arlou Kristina, Janke, Florian, Daum, Ann-Kathrin, Reck, Martin, Schneider, Marc A., Thomas, Michael, Christopoulos, Petros, Sültmann, Holger
Publicado 2023

Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to f...

por Bozorgmehr, Farastuk, Chung, Inn, Christopoulos, Petros, Krisam, Johannes, Schneider, Marc A., Brückner, Lena, Mueller, Daniel Wilhelm, Thomas, Michael, Rieken, Stefan
Publicado 2023

Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma

por Schneider, Marc A., Muley, Thomas, Kahn, Nicolas C., Warth, Arne, Thomas, Michael, Herth, Felix J.F., Dienemann, Hendrik, Meister, Michael
Publicado 2016

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durval...

por Bozorgmehr, Farastuk, Chung, Inn, Christopoulos, Petros, Krisam, Johannes, Schneider, Marc A., Brückner, Lena, Mueller, Daniel Wilhelm, Thomas, Michael, Rieken, Stefan
Publicado 2020

Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer

por Weber, Rebecca, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger, Warth, Arne, Winter, Hauke, Herth, Felix J.F., Schneider, Marc A.
Publicado 2018

Establishment of a Tissue-Mimicking Surrogate for Pulmonary Lesions to Improve the Development of RFA Instruments and Algorithms

por Bühler, Louisa, Enderle, Markus D., Kahn, Nicolas, Polke, Markus, Schneider, Marc A., Heußel, Claus Peter, Herth, Felix J. F., Linzenbold, Walter
Publicado 2022

Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protoco...

por Christopoulos, Petros, Bozorgmehr, Farastuk, Brückner, Lena, Chung, Inn, Krisam, Johannes, Schneider, Marc A., Stenzinger, Albrecht, Eickhoff, Regina, Mueller, Daniel W., Thomas, Michael
Publicado 2021

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

por Schneider, Marc A., Rozy, Adriana, Wrenger, Sabine, Christopoulos, Petros, Muley, Thomas, Thomas, Michael, Meister, Michael, Welte, Tobias, Chorostowska-Wynimko, Joanna, Janciauskiene, Sabina
Publicado 2022

Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma

por Schneider, Marc A., Richtmann, Sarah, Gründing, Anna R., Wrenger, Sabine, Welte, Tobias, Meister, Michael, Kriegsmann, Mark, Winter, Hauke, Muley, Thomas, Janciauskiene, Sabina
Publicado 2022

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

por Richtmann, Sarah, Wilkens, Dennis, Warth, Arne, Lasitschka, Felix, Winter, Hauke, Christopoulos, Petros, Herth, Felix J. F., Muley, Thomas, Meister, Michael, Schneider, Marc A.
Publicado 2019

Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers

por Trefzer, Timo B., Schneider, Marc A., Jechow, Katharina, Chua, Robert Lorenz, Muley, Thomas, Winter, Hauke, Kriegsmann, Mark, Meister, Michael, Eils, Roland, Conrad, Christian
Publicado 2022

AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients

por Schneider, Marc A., Christopoulos, Petros, Muley, Thomas, Warth, Arne, Klingmueller, Ursula, Thomas, Michael, Herth, Felix J.F., Dienemann, Hendrik, Mueller, Nikola S., Theis, Fabian, Meister, Michael
Publicado 2017

Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients

por Janke, Florian, Angeles, Arlou Kristina, Riediger, Anja Lisa, Bauer, Simone, Reck, Martin, Stenzinger, Albrecht, Schneider, Marc A., Muley, Thomas, Thomas, Michael, Christopoulos, Petros, Sültmann, Holger
Publicado 2022

Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured

por Kahn, Nicolas, Riedlinger, Julia, Roeßler, Markus, Rabe, Christina, Lindner, Michael, Koch, Ina, Schott-Hildebrand, Sabine, Herth, Felix J, Schneider, Marc A, Meister, Michael, Muley, Thomas R
Publicado 2015

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

por Küster, Miriam M., Schneider, Marc A., Richter, Antje M., Richtmann, Sarah, Winter, Hauke, Kriegsmann, Mark, Pullamsetti, Soni S., Stiewe, Thorsten, Savai, Rajkumar, Muley, Thomas, Dammann, Reinhard H.
Publicado 2020

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

por Bozorgmehr, Farastuk, Christopoulos, Petros, Chung, Inn, Cvetkovic, Jelena, Feißt, Manuel, Krisam, Johannes, Schneider, Marc A., Heußel, Claus Peter, Kreuter, Michael, Müller, Daniel W., Thomas, Michael, Rieken, Stefan
Publicado 2022

Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection

por Dragani, Tommaso A., Muley, Thomas, Schneider, Marc A., Kobinger, Sonja, Eichhorn, Martin, Winter, Hauke, Hoffmann, Hans, Kriegsmann, Mark, Noci, Sara, Incarbone, Matteo, Tosi, Davide, Franzi, Sara, Colombo, Francesca
Publicado 2023

Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma

por Fisch, David, Bozorgmehr, Farastuk, Kazdal, Daniel, Kuon, Jonas, Klotz, Laura V., Shah, Rajiv, Eichhorn, Florian, Kriegsmann, Mark, Schneider, Marc A., Muley, Thomas, Stenzinger, Albrecht, Bischoff, Helge, Christopoulos, Petros
Publicado 2021

Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

por Schneider, Marc A., Muley, Thomas, Weber, Rebecca, Wessels, Sabine, Thomas, Michael, Herth, Felix J. F., Kahn, Nicolas C., Eberhardt, Ralf, Winter, Hauke, Heussel, Gudula, Warth, Arne, Herold-Mende, Christel, Meister, Michael
Publicado 2018

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

por Angeles, Arlou Kristina, Christopoulos, Petros, Yuan, Zhao, Bauer, Simone, Janke, Florian, Ogrodnik, Simon John, Reck, Martin, Schlesner, Matthias, Meister, Michael, Schneider, Marc A., Dietz, Steffen, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Publicado 2021